UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000035224
Receipt number R000040140
Scientific Title Prospective Multicenter Feasibility Study of HANAROSTENT Naturfit Colonic Stent
Date of disclosure of the study information 2018/12/12
Last modified on 2019/03/17 11:49:42

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Prospective Multicenter Feasibility Study of HANAROSTENT Naturfit Colonic Stent

Acronym

HANAROSTENT Naturfit Colonic Stent prospective feasibility study

Scientific Title

Prospective Multicenter Feasibility Study of HANAROSTENT Naturfit Colonic Stent

Scientific Title:Acronym

HANAROSTENT Naturfit Colonic Stent prospective feasibility study

Region

Japan


Condition

Condition

malignant colo-rectal strictures

Classification by specialty

Gastroenterology Gastrointestinal surgery Radiology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

The objective of this registry is to compile clinical experience of use of the HANAROSTENT Naturfit Colonic Stent for the treatment of malignant colo-rectal strictures.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

Clinical Efficacy of HANAROSTENT Naturfit Colonic Stent, associated to Obstruction Relief and Permeability

Key secondary outcomes

Additional data related to the procedure and the product: Technical success, Complications, Survival, Palliation vs Bridge to Surgery


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients requiring palliative treatment of colorectal strictures produced by malignant neoplasms.
Only patients with no previous colonic stenting will be included in the registry.

Key exclusion criteria

Patients contraindicated will include those presenting
- enteral ischemia
- benign stricture
- suspected or impending perforation
- intrabdominal abscess / perforation
- strictures that do not allow passage of a guide wire
- patients for whom endoscopic techniques are contraindicated
- any use other than those specifically outlined under indications of use
(inclusion)

Target sample size

200


Research contact person

Name of lead principal investigator

1st name Shuji
Middle name
Last name Saito

Organization

Yokohama Shin-Midori General Hospital

Division name

Division of Surgery, Gastrointestinal Center

Zip code

226-0025

Address

1726-7 Tokaichiba-cho, Midori-ku, Yokohama

TEL

045-984-2400

Email

shusaito@jb3.so-net.ne.jp


Public contact

Name of contact person

1st name Ryo
Middle name
Last name Otsuka

Organization

Yokohama Shin-Midori General Hospital

Division name

Division of Surgery, Gastrointestinal Center

Zip code

226-0025

Address

1726-7 Tokaichiba-cho, Midori-ku, Yokohama

TEL

045-984-2400

Homepage URL

http://colon-stent.com/

Email

rotsuka7791@gmail.com


Sponsor or person

Institute

Colonic Stent Safe Procedure Research Group

Institute

Department

Personal name



Funding Source

Organization

Colonic Stent Safe Procedure Research Group

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Yokohama Shin-Midori General Hospital,IRB

Address

1726-7 Tokaichiba-cho, Midori-ku, Yokohama

Tel

045-984-2400

Email

nakayama@shinmidori.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2018 Year 12 Month 12 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2018 Year 10 Month 31 Day

Date of IRB

2018 Year 10 Month 31 Day

Anticipated trial start date

2019 Year 02 Month 24 Day

Last follow-up date

2023 Year 10 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

2018 Dec. Planning to start


Management information

Registered date

2018 Year 12 Month 11 Day

Last modified on

2019 Year 03 Month 17 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000040140


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name